SCHEMBL24935698

SCHEMBL24935698

CCc1ccc(C(=O)NC[C@H]2CC[C@H](C(=O)C(C)C)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.51
HDAC3 O15379 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
HDAC4 P56524 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
MAPK14 Q16539 7/20 0.47
P2RX3 P56373 1/20 0.45
PLK1 P53350 1/20 0.44
OPRM1 P35372 2/20 0.44
OPRK1 P41145 2/20 0.44
OPRD1 P41143 1/20 0.44
POLB P06746 1/20 0.44
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17847332 0.88 MAPK14 (0.57) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL25064142 0.86 HDAC6 (0.49) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL17847319 0.82 HDAC6 (0.57) ACACBHDAC3HDAC6MAPK14PLK1
SCHEMBL13484343 0.81 HDAC6 (0.63) HDAC6PLK1POLBMMP13MLYCD
SCHEMBL25064145 0.75 HDAC6 (0.49) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL104788 0.75 MAPK14 (0.56) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL21907222 0.74 MAPK14 (0.52) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL8269158 0.74 HDAC3 (0.50) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL1169741 0.73 MAPK14 (0.54) ACACBHDAC3HDAC6HDAC4HDAC1
SCHEMBL13972889 0.73 PLK1 (0.55) ACACBHDAC3MAPK14PLK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed